← Insider buys
KPTI

Karyopharm Therapeutics Inc. · Healthcare

Chief Scientific Officer Sharon Shacham sold $133K of Karyopharm Therapeutics Inc.

Sold$132,851
$9.86Price
13,471Shares
−1%Stake

What KPTI did after the filing

Prices for KPTI after this filing aren't in yet.

Traded Mon, Feb 7. Filed Wed, Feb 9, 12:22 PM ET, during the session. Not investment advice.